JP2023113803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023113803A5 JP2023113803A5 JP2023092903A JP2023092903A JP2023113803A5 JP 2023113803 A5 JP2023113803 A5 JP 2023113803A5 JP 2023092903 A JP2023092903 A JP 2023092903A JP 2023092903 A JP2023092903 A JP 2023092903A JP 2023113803 A5 JP2023113803 A5 JP 2023113803A5
- Authority
- JP
- Japan
- Prior art keywords
- unit dose
- unit
- succinate
- dosage form
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003890 succinate salts Chemical class 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 4
- ANJTVLIZGCUXLD-BDAKNGLRSA-N (-)-Cytisine Natural products C1NC[C@@H]2CN3C(=O)C=CC=C3[C@H]1C2 ANJTVLIZGCUXLD-BDAKNGLRSA-N 0.000 claims 3
- ANJTVLIZGCUXLD-DTWKUNHWSA-N cytisine Chemical compound C1NC[C@H]2CN3C(=O)C=CC=C3[C@@H]1C2 ANJTVLIZGCUXLD-DTWKUNHWSA-N 0.000 claims 3
- 229940027564 cytisine Drugs 0.000 claims 3
- 229930017327 cytisine Natural products 0.000 claims 3
- ANJTVLIZGCUXLD-UHFFFAOYSA-N ent-cytisine Natural products C1NCC2CN3C(=O)C=CC=C3C1C2 ANJTVLIZGCUXLD-UHFFFAOYSA-N 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000000945 filler Substances 0.000 claims 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 208000025569 Tobacco Use disease Diseases 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-M succinate(1-) Chemical compound OC(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-M 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
- 229940100445 wheat starch Drugs 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024219787A JP2025038099A (ja) | 2016-02-05 | 2024-12-16 | シチシンのコハク酸塩およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1602145.3 | 2016-02-05 | ||
| GBGB1602145.3A GB201602145D0 (en) | 2016-02-05 | 2016-02-05 | Salt |
| JP2021000114A JP7292316B2 (ja) | 2016-02-05 | 2021-01-04 | シチシンのコハク酸塩およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021000114A Division JP7292316B2 (ja) | 2016-02-05 | 2021-01-04 | シチシンのコハク酸塩およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024219787A Division JP2025038099A (ja) | 2016-02-05 | 2024-12-16 | シチシンのコハク酸塩およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023113803A JP2023113803A (ja) | 2023-08-16 |
| JP2023113803A5 true JP2023113803A5 (enExample) | 2024-03-19 |
Family
ID=55641904
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541196A Active JP6820344B2 (ja) | 2016-02-05 | 2017-02-06 | シチシンのコハク酸塩およびその使用 |
| JP2021000114A Active JP7292316B2 (ja) | 2016-02-05 | 2021-01-04 | シチシンのコハク酸塩およびその使用 |
| JP2023092903A Withdrawn JP2023113803A (ja) | 2016-02-05 | 2023-06-06 | シチシンのコハク酸塩およびその使用 |
| JP2024219787A Pending JP2025038099A (ja) | 2016-02-05 | 2024-12-16 | シチシンのコハク酸塩およびその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541196A Active JP6820344B2 (ja) | 2016-02-05 | 2017-02-06 | シチシンのコハク酸塩およびその使用 |
| JP2021000114A Active JP7292316B2 (ja) | 2016-02-05 | 2021-01-04 | シチシンのコハク酸塩およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024219787A Pending JP2025038099A (ja) | 2016-02-05 | 2024-12-16 | シチシンのコハク酸塩およびその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10300050B2 (enExample) |
| EP (2) | EP3411029B1 (enExample) |
| JP (4) | JP6820344B2 (enExample) |
| KR (4) | KR20180121900A (enExample) |
| CN (1) | CN108883101A (enExample) |
| AU (2) | AU2017215300B2 (enExample) |
| CA (1) | CA3013454C (enExample) |
| DK (1) | DK3411029T3 (enExample) |
| ES (1) | ES2963451T3 (enExample) |
| GB (2) | GB201602145D0 (enExample) |
| MX (1) | MX372607B (enExample) |
| PL (1) | PL3411029T3 (enExample) |
| PT (1) | PT3411029T (enExample) |
| SI (1) | SI3411029T1 (enExample) |
| SM (1) | SMT202300416T1 (enExample) |
| WO (1) | WO2017134468A1 (enExample) |
| ZA (1) | ZA201805296B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201602145D0 (en) | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| US11459328B2 (en) | 2017-07-24 | 2022-10-04 | Achieve Pharma Uk Limited | Cytisine salts |
| EP3598968A1 (en) * | 2018-07-23 | 2020-01-29 | Adamed Pharma S.A. | Solid pharmaceutical cytisine composition |
| US11083715B2 (en) * | 2019-09-12 | 2021-08-10 | Achieve Life Sciences, Inc. | Compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof |
| CN116509857A (zh) * | 2023-04-11 | 2023-08-01 | 广州医科大学 | 金雀花碱的新应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698224A (en) | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
| WO1996027303A1 (en) | 1995-03-06 | 1996-09-12 | Lectec Corporation | Nicotine-free smoking material |
| US6235734B1 (en) | 1996-10-30 | 2001-05-22 | Pfizer Inc | Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| RU2228179C2 (ru) | 2002-07-22 | 2004-05-10 | Институт органической химии Уфимского научного центра РАН | Гидрохлорид n-(бета-гидроксиэтил)цитизина, проявляющий антиаритмическую активность |
| US20050159471A1 (en) | 2003-05-14 | 2005-07-21 | Pharmacia Corporation | Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system |
| BG65536B1 (bg) | 2004-04-16 | 2008-11-28 | "Софарма" Ад | Лекарствена форма, съдържаща цитизин |
| US20100048606A1 (en) * | 2006-03-29 | 2010-02-25 | Georgetown University Office of Technology Commercialization | 10-Substituted Cytisine Derivatives and Methods of Use Thereof |
| CN101428021B (zh) * | 2007-11-09 | 2012-07-18 | 江苏中康药物科技有限公司 | 一种用于戒除烟瘾酒瘾的外用药物制剂 |
| US9233109B2 (en) | 2010-04-23 | 2016-01-12 | University Of Florida Research Foundation, Inc. | Compositions, methods of use, and methods of treatment |
| CN102167680B (zh) | 2011-03-23 | 2014-07-02 | 合亚医药科技（上海）有限公司 | 八氢环戊基并[c]吡咯羧酸衍生物的制备方法 |
| BR112013032415B1 (pt) * | 2011-06-17 | 2021-07-27 | Pfizer Anti-Infectives Ab | Processos para preparar compostos e compostos |
| CN103044423B (zh) | 2012-01-11 | 2013-10-23 | 上海合全药物研发有限公司 | 取代的吡啶-2-酮类化合物及其制备方法 |
| CN103509021B (zh) | 2012-06-21 | 2016-08-17 | 天津药明康德新药开发有限公司 | 金雀花碱衍生物及其制备方法和抗癌作用研究 |
| FR2992315B1 (fr) | 2012-06-25 | 2014-08-08 | Pf Medicament | Derives utiles dans le traitement de maladies du systeme nerveux central |
| US20170209415A1 (en) | 2012-08-13 | 2017-07-27 | Anthony Alexander McKINNEY | Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive disorders including nicotine addiction |
| PL220354B1 (pl) * | 2012-11-19 | 2015-10-30 | Aflofarm Fabryka Leków Spółka Z Ograniczoną Odpowiedzialnością | Stała postać dawkowania zawierająca zmikronizowaną cytyzynę oraz sposób jej otrzymywania |
| CN102952134B (zh) | 2012-12-05 | 2015-01-07 | 苏州药明康德检测检验有限责任公司 | 含二氟甲基的金雀花碱衍生物及制备方法和抗癌作用研究 |
| CN103284319A (zh) | 2013-06-20 | 2013-09-11 | 昌宁德康生物科技有限公司 | 一种金雀花碱替代尼古丁口腔雾化液及其制备方法 |
| GB201315030D0 (en) * | 2013-08-22 | 2013-10-02 | Knight Martin | Magazine |
| WO2015025718A1 (ja) * | 2013-08-23 | 2015-02-26 | 久光製薬株式会社 | 貼付剤 |
| CN103588773B (zh) | 2013-11-07 | 2016-01-06 | 东南大学 | 一种金雀花碱的提取分离方法 |
| CN104710422A (zh) * | 2013-12-13 | 2015-06-17 | 上海壹志医药科技有限公司 | 金雀花碱衍生物 |
| PL408608A1 (pl) | 2014-06-18 | 2015-12-21 | Pharmacia Polonica Spółka Z Ograniczoną Odpowiedzialnością | Trwała stała kompozycja farmaceutyczna cytyzyny oraz sposób jej wytwarzania |
| PL409830A1 (pl) | 2014-10-18 | 2016-04-25 | Łukasz Zalewski | Papieros z cytyzyną |
| GB201602145D0 (en) * | 2016-02-05 | 2016-03-23 | Achieve Pharma Uk Ltd | Salt |
| CN106188057A (zh) | 2016-07-21 | 2016-12-07 | 西安岳达生物科技股份有限公司 | 一种金雀花碱的分离提取方法 |
| JP7178538B2 (ja) | 2016-08-19 | 2022-11-28 | ザ ユニバーシティ オブ ブリストル | 化合物 |
-
2016
- 2016-02-05 GB GBGB1602145.3A patent/GB201602145D0/en not_active Ceased
-
2017
- 2017-02-06 KR KR1020187025475A patent/KR20180121900A/ko not_active Ceased
- 2017-02-06 ES ES17704814T patent/ES2963451T3/es active Active
- 2017-02-06 CA CA3013454A patent/CA3013454C/en active Active
- 2017-02-06 PT PT177048147T patent/PT3411029T/pt unknown
- 2017-02-06 SI SI201731450T patent/SI3411029T1/sl unknown
- 2017-02-06 EP EP17704814.7A patent/EP3411029B1/en active Active
- 2017-02-06 KR KR1020247042937A patent/KR20250004182A/ko active Pending
- 2017-02-06 JP JP2018541196A patent/JP6820344B2/ja active Active
- 2017-02-06 GB GB1701939.9A patent/GB2550241B/en active Active
- 2017-02-06 CN CN201780009979.0A patent/CN108883101A/zh active Pending
- 2017-02-06 AU AU2017215300A patent/AU2017215300B2/en active Active
- 2017-02-06 KR KR1020247009722A patent/KR20240042257A/ko not_active Ceased
- 2017-02-06 US US16/075,902 patent/US10300050B2/en active Active
- 2017-02-06 EP EP23197173.0A patent/EP4265298A3/en active Pending
- 2017-02-06 KR KR1020257017169A patent/KR20250078632A/ko active Pending
- 2017-02-06 SM SM20230416T patent/SMT202300416T1/it unknown
- 2017-02-06 PL PL17704814.7T patent/PL3411029T3/pl unknown
- 2017-02-06 WO PCT/GB2017/050294 patent/WO2017134468A1/en not_active Ceased
- 2017-02-06 DK DK17704814.7T patent/DK3411029T3/da active
- 2017-02-06 MX MX2018009364A patent/MX372607B/es active IP Right Grant
-
2018
- 2018-08-10 ZA ZA2018/05296A patent/ZA201805296B/en unknown
-
2021
- 2021-01-04 JP JP2021000114A patent/JP7292316B2/ja active Active
-
2022
- 2022-06-02 AU AU2022203808A patent/AU2022203808B2/en active Active
-
2023
- 2023-06-06 JP JP2023092903A patent/JP2023113803A/ja not_active Withdrawn
-
2024
- 2024-12-16 JP JP2024219787A patent/JP2025038099A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023113803A5 (enExample) | ||
| JP4989733B2 (ja) | 口腔内崩壊錠 | |
| CN103096881B (zh) | 含有具有不愉快味道的药物的膜制剂 | |
| JP2001511184A (ja) | デスカルボエトキシロラタディンのラクトースを含まず非吸湿性かつ無水の薬剤組成物 | |
| JP2008540356A (ja) | 薬物乱用の治療方法 | |
| EP2295041A2 (en) | HRT formulations | |
| JP2001172181A (ja) | 経口投与後のトリメタジジンの持続性放出を可能とするマトリックス錠 | |
| JP2008511569A (ja) | 注意欠如活動過多障害の治療方法 | |
| KR20150002550A (ko) | 타다라필 및 탐수로신을 함유하는 약학적 캡슐 복합 제제 | |
| TWI841539B (zh) | 雙層醫藥錠劑調配物 | |
| EP2200614B1 (en) | Treatment of vasomotor symptoms | |
| JP2019504848A5 (enExample) | ||
| EP1567133B1 (en) | Pharmaceutical antiviral compositions | |
| TW201318650A (zh) | 口崩片組成物 | |
| JP5491040B2 (ja) | アカルボースを含有する錠剤 | |
| CN100418526C (zh) | 依贝沙坦在制备用来预防或治疗肺动脉高压的药物中的应用 | |
| US6653339B2 (en) | Method of treating irritable bowel syndrome | |
| KR20150032048A (ko) | 안정성이 개선된 다층 고형 제제 | |
| WO2018091609A1 (en) | Formulation comprising 4-methylpyrazole | |
| RU2007125596A (ru) | Комбинированный противотуберкулезный препарат | |
| CN112263581A (zh) | 一种治疗pe和ed的双层片复方制剂及其制备方法 | |
| WO2008061966A2 (en) | New use of flibanserin | |
| JP2018030841A (ja) | 固形製剤、錠剤の製造方法およびコーティング錠の製造方法 | |
| BRPI0612990A2 (pt) | formulação de liberação prolongada de princìpios ativos de medicamentos | |
| UA146313U (uk) | Готовий лікарський засіб для симптоматичного лікування хронічного запору |